One year survival of HIV-infected veterans with CD4 < 100 cells/mm3: data from a veteran cohort

AIDS Care
Katharine BreauxMaria C Rodriguez-Barradas

Abstract

Survival among HIV-infected patients markedly improved with the introduction of highly active antiretroviral therapy (HAART). Easier to take and more effective HAART options have improved the one-year virologic success rate among naive patients. Numerous studies have shown that initiating HAART and restoration of CD4 cells positively impact survival. There are only a few evaluations that have been carried out on the changes in survival among patients who are severely immunosuppressed. We evaluated survival among a cohort of veterans with CD4<100 cells/mm(3) (CD4 < 100) in three time periods reflecting early, mid, and recent HAART. Using the HIV clinic database, all patients with CD4 < 100 seen between 1996 and 2004 were identified (n=394). Patients entered Cohorts 1 (n=219), 2 (n=72), and 3 (n=103) in 1996-1998, 1999-2001, and 2002-2004, respectively. Data on demographics, AIDS-defining illnesses, co-morbidities, treatment, CD4, and viral load (VL) were abstracted. Survival analysis controlling for the above variables was performed and odds ratios with 95% confidence intervals were calculated. Rate of virologic suppression was higher for Cohort 2 when compared to Cohort 1 (63% vs. 46%, p<0.05), but lower for Cohort 3 when compa...Continue Reading

References

Dec 26, 2001·Journal of Clinical Epidemiology·A M KilbourneUNKNOWN VACS 3 Project Team
Oct 17, 2002·Drugs & Aging·Roberto Manfredi
Aug 9, 2005·The American Journal of Medicine·R Scott BraithwaiteMark S Roberts
Jan 6, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Nancy F CrumUNKNOWN Triservice AIDS Clinical Consortium
Apr 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nina WeisNiels Obel
Jul 20, 2006·Medical Care·Amy C JusticeKendall Bryant
Aug 1, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Frank J PalellaUNKNOWN HIV Outpatient Study Investigators
Sep 20, 2006·Annals of Internal Medicine·Judith E SackoffLucia V Torian
Dec 1, 2006·The New England Journal of Medicine·UNKNOWN Strategies for Management of Antiretroviral Therapy (SMART) Study GroupC Rappoport
May 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas P GiordanoRobert O Morgan
Nov 29, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·UNKNOWN Antiretroviral Therapy Cohort Collaboration
Jul 17, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rita B EffrosKevin P High
Jul 17, 2008·Current HIV/AIDS Reports·Kavita P BhavanEdgar Turner Overton
Oct 4, 2008·AIDS·Antonella d'Arminio MonforteUNKNOWN Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group
Mar 26, 2009·Medical Care·Tuyen HoangSteven M Asch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.